drugset / Trial / NCT02268136
Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective ot the present study is to obtain information about safety, tolerability and preliminary pharmacokinetics of BIII 890 CL after single intravenous administration of increasing doses in healthy male volunteers.
Timeline
- Start
- 1999-04
- Primary completion
- 1999-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crobenetine | Small molecule | 0.5 mg | Intravenous |
| Subject | Crobenetine | Small molecule | 80 mg | Intravenous |
Indications
No indication recorded.